Developer docs
API playgroundTry for free, no card

Search company profiles

Mary's Medicinals

Full company profile

uuid000jkya

Namestring
Mary's Medicinals
Legal namestring
Mary's Medicinals
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Mary's Medicinals, founded in 2013 in Colorado and operating as a subsidiary of MM Brands Inc., is a cannabis wellness company that develops, manufactures, and distributes transdermal and topical cannabinoid products as well as sublingual tinctures. Its core technology is a transdermal cannabis delivery system that enables cannabinoids to penetrate the skin barrier and enter the bloodstream directly, bypassing first-pass liver metabolism and stomach acid breakdown. The company pioneered the first transdermal cannabis patch on the market and holds patents on a transdermal gel pen delivery system for precise dosing. Its product portfolio includes award-winning 2x2 inch transdermal patches in multiple formulations (Relief 1:1 CBD:THC, FORMULA 3:2:1 THC:CBD:CBN, Relax Indica, Energy Sativa, Focus CBG, Sleep CBN, Recover THCa), topical creams and balms, and the Remedy line of sublingual oils in varied cannabinoid ratios.

The company sells through two parallel channels: licensed dispensaries in California, Colorado, Michigan, Missouri, and Ohio for marijuana-derived products, and a hemp-derived product line through marysnutritionals.com that ships nationally. Pricing is set at the dispensary level and is not directly disclosed. The go-to-market strategy is product-led with content-marketing and educational-support depth (Mary's Learn portal, blog, social media, partnership with cannabis-trained nurse service LEAF411, and prominent customer-review and dispensary-staff endorsement loops) targeting medical cannabis patients and cannabis-curious wellness consumers seeking discreet, controlled, sustained dosing for pain, sleep, focus, and recovery.

In April 2026 the company announced its intention to participate in a CMS Medicare/Medicaid cannabinoid therapy trial program starting in 2027, which would open federally reimbursed healthcare channels through ACO REACH and the Enhancing Oncology Model for products containing up to 3 mg THC per serving. The company has 11–50 employees, has not disclosed funding or revenue, and is led operationally by a small disclosed team including Eduardo Provencio as Data Controller.

Short descriptiontext

Mary's Medicinals, founded in 2013 in Colorado, develops and sells patented transdermal cannabis patches, topical creams, and sublingual tinctures through licensed dispensaries in five US states and a parallel hemp e-commerce platform, serving medical cannabis patients and wellness consumers seeking discreet, controlled dosing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMadison, United States
HQ citystring
Madison
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cannabis wellness products, transdermal cannabis patches, topical cannabis balms, sublingual cannabis tinctures, hemp extract supplements
Industry3 codes
1CBD/Hemp Wellness & Supplements Retail
CodeCRANAHACPrimaryYes
2CBD/Hemp Topicals & Beauty Retail
CodeCRANAHABPrimaryNo
3Medical Cannabis Dispensaries
CodeCRANAFABPrimaryNo
NAICS code3 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical and Medicine Manufacturing32541
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Cannabis Wellness Products
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Cannabis Product Sales
TypeOne Time License
Description

One-time product sales through licensed dispensaries in states with legal cannabis programs. Products include transdermal patches, topical creams, and sublingual tinctures containing THC, CBD, and other cannabinoids.

marysmedicinals.com
2Hemp-Derived Product Sales
TypeOne Time License
Description

E-commerce sales of hemp-derived cannabinoid products through sister brand marysnutritionals.com, which can ship nationally across state lines

marysmedicinals.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Mary's Medicinals develops, manufactures, and sells cannabis- and hemp-based transdermal patches, topical creams and balms, sublingual tinctures, and gel pens. Its THC-bearing product line is sold through licensed dispensaries in California, Colorado, Michigan, Missouri, and Ohio, while its hemp-derived wellness line is sold through a direct-to-consumer e-commerce storefront.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Transdermal delivery eliminates up to 70% losses from smoking/edibles due to vaporization, metabolism, and stomach acid
+2 more records
Product overview1 text field

Mary's Medicinals is a cannabis wellness company that develops and manufactures transdermal and topical cannabinoid products as well as sublingual consumables. The company pioneered the first transdermal cannabis patch and holds patents for transdermal gel pen technology. The product portfolio centers on two delivery systems: transdermal patches (including award-winning 2x2 inch patches in various formulations) that deliver cannabinoids directly into the bloodstream for systemic 8-12 hour relief, and topical creams/balms for localized application. Additionally, The Remedy sublingual oil line offers consumable tinctures in multiple cannabinoid ratios. Products are available in state-specific formulations including California, Colorado, Michigan, Missouri, and Ohio, with different cannabinoid combinations (CBD, THC, CBG, CBN, THCa) tailored for effects like relief, relaxation, energy, focus, sleep, and recovery. The company also offers a separate hemp-derived product line through MarysNutritionals.com for national shipping.

Product and service5 records
1Transdermal Cannabis Patches
CategoryTransdermal cannabis products
Description

Discreet adhesive patches that deliver cannabinoids through the skin for sustained, smokeless, precisely dosed relief; targeted at adult cannabis consumers seeking an inhalation-free alternative.

2Topical Cannabis Creams and Balms
CategoryTopical cannabis products
Description

Skin-applied cannabis creams and balms designed for localized relief; targeted at adult cannabis patients/consumers preferring non-systemic, topical options.

3Sublingual Cannabis Tinctures
CategoryOral cannabis products
Description

Liquid cannabis tinctures administered under the tongue for faster onset than ingestibles; targeted at adult consumers who prefer non-inhalation dosing.

4Transdermal Gel Pens
CategoryTransdermal cannabis products
Description

Patented gel pens that deliver cannabis formulation transdermally; targeted at adult consumers seeking metered, portable transdermal application.

5Mary's Nutritionals Hemp-Derived Line
CategoryHemp wellness products
Description

Hemp-derived (federally legal) versions of patches, topicals, and tinctures sold direct-to-consumer online; targeted at general wellness consumers nationwide who cannot access state-licensed THC dispensaries.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeGTM or Marketing Partner
Description

Mary's Medicinals partners with LEAF411, a cannabis-trained nurse consultation service. LEAF411 provides free or discounted consultations for Mary's customers using code MARYSMN. The partnership enables patient education on safe and effective cannabis use and product guidance. LEAF411 believes everyone deserves affordable, accessible medical guidance and education to use cannabis safely and effectively.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cannabis wellness/edible brand that was publicly traded and focused on low-dose, health-positioned SKUs; comparable as a brand-led cannabis wellness company with similar consumer positioning around controlled dosing.

TypeDirect peer
Description

California-based cannabis wellness brand with a strong topicals, tinctures, and transdermal patch product line targeted at medical and wellness consumers; the closest direct comparable in transdermal/topical cannabis wellness.

TypeDirect peer
Description

Major California-originated cannabis CPG brand with broad SKU coverage including edibles and wellness products; comparable as a multi-format, award-winning cannabis wellness brand with multi-state dispensary distribution.

TypeDirect peer
Description

One of the largest cannabis edible and wellness brands in North America, distributed across multiple legal states; comparable as a multi-state cannabis wellness CPG with strong brand recognition.

TypeDirect peer
Description

Cannabis wellness company with a topicals, chocolates, and inhaled products line; comparable as a multi-format cannabis wellness brand with national award recognition similar to Mary's.

TypeDirect peer
Description

California-based cannabis CPG producing KANHA gummies and Sundae Shop alongside wellness SKUs; comparable as a multi-state cannabis wellness brand pursuing diversified product formats.

7Foray (by Froot)
TypeDirect peer
Description

Cannabis wellness brand offering low-dose tinctures and topicals targeted at cannabis-curious consumers; comparable as a wellness-positioned brand with a focus on discreet, controlled dosing formats overlapping with Mary's patch/tincture lines.

TypeBroad incumbent
Description

One of the largest US multi-state cannabis operators with broad product portfolios including topicals and patches; comparable as a backdrop competitor that has begun offering transdermal-style products, representing the capital-rich threat to branded niche players like Mary's.

TypeEmerging player
Description

Hemp-derived CBD wellness brand with national e-commerce distribution across topicals, tinctures, and softgels; comparable to Mary's Nutritionals channel as a national hemp e-commerce wellness brand.

TypeEmerging player
Description

National hemp-derived CBD brand selling topicals, tinctures, and patches via e-commerce; comparable to Mary's Nutritionals in providing nationally-shipped hemp wellness products including topical and patch formats.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mary's Medicinals

Cannabis Wellness Productsmarysmedicinals.com

Mary's Medicinals, founded in 2013 in Colorado, develops and sells patented transdermal cannabis patches, topical creams, and sublingual tinctures through licensed dispensaries in five US states and a parallel hemp e-commerce platform, serving medical cannabis patients and wellness consumers seeking discreet, controlled dosing.

What Mary's Medicinals does

Mary's Medicinals, founded in 2013 in Colorado and operating as a subsidiary of MM Brands Inc., is a cannabis wellness company that develops, manufactures, and distributes transdermal and topical cannabinoid products as well as sublingual tinctures. Its core technology is a transdermal cannabis delivery system that enables cannabinoids to penetrate the skin barrier and enter the bloodstream directly, bypassing first-pass liver metabolism and stomach acid breakdown. The company pioneered the first transdermal cannabis patch on the market and holds patents on a transdermal gel pen delivery system for precise dosing. Its product portfolio includes award-winning 2x2 inch transdermal patches in multiple formulations (Relief 1:1 CBD:THC, FORMULA 3:2:1 THC:CBD:CBN, Relax Indica, Energy Sativa, Focus CBG, Sleep CBN, Recover THCa), topical creams and balms, and the Remedy line of sublingual oils in varied cannabinoid ratios.

The company sells through two parallel channels: licensed dispensaries in California, Colorado, Michigan, Missouri, and Ohio for marijuana-derived products, and a hemp-derived product line through marysnutritionals.com that ships nationally. Pricing is set at the dispensary level and is not directly disclosed. The go-to-market strategy is product-led with content-marketing and educational-support depth (Mary's Learn portal, blog, social media, partnership with cannabis-trained nurse service LEAF411, and prominent customer-review and dispensary-staff endorsement loops) targeting medical cannabis patients and cannabis-curious wellness consumers seeking discreet, controlled, sustained dosing for pain, sleep, focus, and recovery.

In April 2026 the company announced its intention to participate in a CMS Medicare/Medicaid cannabinoid therapy trial program starting in 2027, which would open federally reimbursed healthcare channels through ACO REACH and the Enhancing Oncology Model for products containing up to 3 mg THC per serving. The company has 11–50 employees, has not disclosed funding or revenue, and is led operationally by a small disclosed team including Eduardo Provencio as Data Controller.

Mary's Medicinals firmographics

Firmographics
Name
Mary's Medicinals
Legal name
Mary's Medicinals
Website
https://marysmedicinals.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Mary's Medicinals, founded in 2013 in Colorado, develops and sells patented transdermal cannabis patches, topical creams, and sublingual tinctures through licensed dispensaries in five US states and a parallel hemp e-commerce platform, serving medical cannabis patients and wellness consumers seeking discreet, controlled dosing.
Ownership category
akta.pro rank

Mary's Medicinals industry classification

Industry
Product category
Cannabis Wellness Products
NAICS
Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412)
SIC
Medicinal Chemicals & Botanical Products (2833), Perfumes, Cosmetics & Other Toilet Preparations (2844)
akta.pro primary industry
CBD/Hemp Wellness & Supplements Retail (CRANAHAC)
akta.pro secondary industries
CBD/Hemp Topicals & Beauty Retail (CRANAHAB), Medical Cannabis Dispensaries (CRANAFAB)

Keywords

  • Cannabis wellness products
  • Transdermal cannabis patches
  • Topical cannabis balms
  • Sublingual cannabis tinctures
  • Hemp extract supplements

Where Mary's Medicinals is headquartered

Location

Headquarters

HQ city
Madison
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Mary's Medicinals business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D

Revenue model

  1. Cannabis Product Sales: One-time product sales through licensed dispensaries in states with legal cannabis programs. Products include transdermal patches, topical creams, and sublingual tinctures containing THC, CBD, and other cannabinoids.
  2. Hemp-Derived Product Sales: E-commerce sales of hemp-derived cannabinoid products through sister brand marysnutritionals.com, which can ship nationally across state lines

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Mary's Medicinals product offering

Product offering

Core offering

Mary's Medicinals develops, manufactures, and sells cannabis- and hemp-based transdermal patches, topical creams and balms, sublingual tinctures, and gel pens. Its THC-bearing product line is sold through licensed dispensaries in California, Colorado, Michigan, Missouri, and Ohio, while its hemp-derived wellness line is sold through a direct-to-consumer e-commerce storefront.

Product overview

Mary's Medicinals is a cannabis wellness company that develops and manufactures transdermal and topical cannabinoid products as well as sublingual consumables. The company pioneered the first transdermal cannabis patch and holds patents for transdermal gel pen technology. The product portfolio centers on two delivery systems: transdermal patches (including award-winning 2x2 inch patches in various formulations) that deliver cannabinoids directly into the bloodstream for systemic 8-12 hour relief, and topical creams/balms for localized application. Additionally, The Remedy sublingual oil line offers consumable tinctures in multiple cannabinoid ratios. Products are available in state-specific formulations including California, Colorado, Michigan, Missouri, and Ohio, with different cannabinoid combinations (CBD, THC, CBG, CBN, THCa) tailored for effects like relief, relaxation, energy, focus, sleep, and recovery. The company also offers a separate hemp-derived product line through MarysNutritionals.com for national shipping.

Differentiator

Problem solved

Functional benefit

Products and services

  • Transdermal Cannabis Patches Discreet adhesive patches that deliver cannabinoids through the skin for sustained, smokeless, precisely dosed relief; targeted at adult cannabis consumers seeking an inhalation-free alternative.
  • Topical Cannabis Creams and Balms Skin-applied cannabis creams and balms designed for localized relief; targeted at adult cannabis patients/consumers preferring non-systemic, topical options.
  • Sublingual Cannabis Tinctures Liquid cannabis tinctures administered under the tongue for faster onset than ingestibles; targeted at adult consumers who prefer non-inhalation dosing.
  • Transdermal Gel Pens Patented gel pens that deliver cannabis formulation transdermally; targeted at adult consumers seeking metered, portable transdermal application.
  • Mary's Nutritionals Hemp-Derived Line Hemp-derived (federally legal) versions of patches, topicals, and tinctures sold direct-to-consumer online; targeted at general wellness consumers nationwide who cannot access state-licensed THC dispensaries.

Quantifiable outcome

  • Transdermal delivery eliminates up to 70% losses from smoking/edibles due to vaporization, metabolism, and stomach acid
  • +2 more outcomes

Companies that use Mary's Medicinals

Customer profile

Segments2 records

Ideal customer profiles1 record

Mary's Medicinals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Mary's Medicinals partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • LEAF411coreGTM or Marketing PartnerMary's Medicinals partners with LEAF411, a cannabis-trained nurse consultation service. LEAF411 provides free or discounted consultations for Mary's customers using code MARYSMN. The partnership enables patient education on safe and effective cannabis use and product guidance. LEAF411 believes everyone deserves affordable, accessible medical guidance and education to use cannabis safely and effectively.

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

Mary's Medicinals competitors and assessment

Company assessment

Direct peers

  • Plus Products: Cannabis wellness/edible brand that was publicly traded and focused on low-dose, health-positioned SKUs; comparable as a brand-led cannabis wellness company with similar consumer positioning around controlled dosing.
  • Papa & Barkley: California-based cannabis wellness brand with a strong topicals, tinctures, and transdermal patch product line targeted at medical and wellness consumers; the closest direct comparable in transdermal/topical cannabis wellness.
  • Kiva Confections: Major California-originated cannabis CPG brand with broad SKU coverage including edibles and wellness products; comparable as a multi-format, award-winning cannabis wellness brand with multi-state dispensary distribution.
  • Wana Brands: One of the largest cannabis edible and wellness brands in North America, distributed across multiple legal states; comparable as a multi-state cannabis wellness CPG with strong brand recognition.
  • Bhang: Cannabis wellness company with a topicals, chocolates, and inhaled products line; comparable as a multi-format cannabis wellness brand with national award recognition similar to Mary's.
  • Sunderstorm (KANHA): California-based cannabis CPG producing KANHA gummies and Sundae Shop alongside wellness SKUs; comparable as a multi-state cannabis wellness brand pursuing diversified product formats.
  • Foray (by Froot): Cannabis wellness brand offering low-dose tinctures and topicals targeted at cannabis-curious consumers; comparable as a wellness-positioned brand with a focus on discreet, controlled dosing formats overlapping with Mary's patch/tincture lines.

Broad incumbents

  • Curaleaf: One of the largest US multi-state cannabis operators with broad product portfolios including topicals and patches; comparable as a backdrop competitor that has begun offering transdermal-style products, representing the capital-rich threat to branded niche players like Mary's.

Emerging players

  • Joy Organics: Hemp-derived CBD wellness brand with national e-commerce distribution across topicals, tinctures, and softgels; comparable to Mary's Nutritionals channel as a national hemp e-commerce wellness brand.
  • cbdfx: National hemp-derived CBD brand selling topicals, tinctures, and patches via e-commerce; comparable to Mary's Nutritionals in providing nationally-shipped hemp wellness products including topical and patch formats.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Mary's Medicinals social profiles

Digital presence

Mary's Medicinals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mary's Medicinals leadership team

Management profile

Number of profiles

Mary's Medicinals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mary's Medicinals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mary's Medicinals

What does Mary's Medicinals do?

Mary's Medicinals develops, manufactures, and sells cannabis- and hemp-based transdermal patches, topical creams and balms, sublingual tinctures, and gel pens. Its THC-bearing product line is sold through licensed dispensaries in California, Colorado, Michigan, Missouri, and Ohio, while its hemp-derived wellness line is sold through a direct-to-consumer e-commerce storefront.

Is Mary's Medicinals a public or private company?

Mary's Medicinals is a private company. It is classified as corporate owned and is currently operating.

When was Mary's Medicinals founded?

Mary's Medicinals was founded in 2013. It employs 11 to 50 people.

Where is Mary's Medicinals based?

Mary's Medicinals is headquartered in Madison, United States, in the North America region.

How does Mary's Medicinals make money?

Two revenue lines are on record. Cannabis Product Sales are the primary driver. The others are hemp-Derived Product Sales.

Who are Mary's Medicinals's main competitors?

Direct peers on record are Plus Products, Papa & Barkley, Kiva Confections, Wana Brands, Bhang, Sunderstorm (KANHA) and Foray (by Froot). Curaleaf is listed as a broad incumbent. Emerging players are Joy Organics and cbdfx.

Does Mary's Medicinals have an API?

No public API is recorded for Mary's Medicinals.

What industry is Mary's Medicinals in?

Mary's Medicinals's product category is Cannabis Wellness Products. Its primary akta.pro industry code is CRANAHAC, CBD/Hemp Wellness & Supplements Retail, with a secondary code of CRANAHAB, CBD/Hemp Topicals & Beauty Retail. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireMary's Medicinals Announces Its Intention to Participate in the Newly Announced Medicare and Medicaid CMS Trial Program with Its Award-Winning Cannabinoid-Based Wellness ProductsMary's Medicinals, a subsidiary of MM Brands Inc., announced its intention to participate in a newly established Centers for Medicare & Medicaid Services Innovation Center trial program for cannabinoid-based wellness products. The program, launching in 2027 under the Substance Access Beneficiary Engagement Incentive program, will cover products containing up to 3 mg of THC per serving, enabling access through ACO REACH and the Enhancing Oncology Model. The initiative aims to evaluate cannabinoids' impact on patient outcomes as alternatives to traditional pharmaceutical therapies such as opioids and synthetic prescription drugs.MorningstarMary's Medicinals Announces Its Intention to Participate in the Newly Announced Medicare and Medicaid CMS Trial Program with Its Award-Winning Cannabinoid-Based Wellness ProductsMary's Medicinals, a subsidiary of MM Brands Inc., announced its intention to participate in a newly established CMS Innovation Center trial program for cannabinoid-based wellness products launched on April 1, 2026. The program sets eligibility for products containing up to 3 mg of THC per serving and aims to evaluate cannabinoids' impact on patient outcomes as alternatives to traditional pharmaceutical therapies. Eligible patients will gain access through the LEAD model starting in 2027 under the ACO REACH program and Enhancing Oncology Model.Daily HeraldTime short for Schaumburg family’s quest to retain access to daughter’s medical marijuanaA Schaumburg, Illinois family is racing against time to retain access to medical marijuana patches for their 19-year-old daughter Ashley, who has relied on them for eight years to prevent epileptic seizures. Mary's Medicinals of Colorado withdrew from the Illinois market, leaving Green Thumb Industries as the local manufacturer, and the family's supply will be depleted in two weeks with no legal path to purchase from other states. The family, which previously inspired Ashley's Law in 2018, is advocating for changes to interstate commerce laws, while an executive order from President Trump on marijuana reclassification offers cautious optimism.PR NewswireMary's Medicinals and Dixie Brands Are Honored with Multiple Cannabis Industry RecognitionsBellRock Brands announced that its subsidiary brands Mary's Medicinals and Dixie Brands received multiple industry awards from BDSA and LeafLink for top sales in categories such as topicals, ingestibles, and beverages during the first half of 2021. The recognition highlights strong market performance for BellRock's portfolio, which currently operates across nine U.S. states. Additionally, Dixie Brands expanded its product line in Michigan with new gummy SKUs through a partnership with manufacturer JRMI27.GlobeNewswireEntourage Health Launches Mary’s Medicinals Transdermal Cannabis Patches in CanadaEntourage Health launched Mary's Medicinals Transdermal Patches in Canada, offering CBD, THC, and 1:1 formulations. The patches are available first to Starseed Medicinal patients from late September 2021, with retail expansion expected later this year. The company also expects to close its CannTx acquisition by October 2021.PR NewswireLiberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Mary's Medicinals Cannabis Products to MassachusettsLiberty Health Sciences has signed an exclusive agreement with Mary's Medicinals to produce and distribute its cannabis products in Massachusetts, pending regulatory approval. This partnership expands Liberty's existing collaboration with Mary's, which previously covered Florida, granting Liberty exclusive rights to sell various innovative delivery methods such as transdermal patches and tinctures.PR NewswireLeading International Medical Cannabis Experts from Science & Business to Highlight CannaTech 2018The CannaTech Innovation Summit 2018 will be held March 19-20 in Tel Aviv, Israel, bringing together leading international medical cannabis experts from science and business. Economists project the overall cannabis-related goods and products market could be worth tens of billions of dollars in the next decade. Speakers at the summit will include representatives from companies such as Canopy Growth, Arcview Group, Hoban Law Group, Mary's Medicinals, and Nuuvera, covering topics including agricultural research, regulation, medical research, and investment.PR NewswireMary's Medicinals Names Lynn Honderd CEOMary's Medicinals announced Lynn Honderd as its new chief executive officer, succeeding Nicole Smith who recently stepped down from the role. Honderd previously served as chief operating officer and co-founded the company in 2013. With recent expansion into Illinois and Nevada, the company now operates in eight states with plans to enter three additional states by mid-2017.PR NewswireWhat is CBD? The Everyday Guide to CannabidiolCannaInsider.com has published a comprehensive guide to cannabidiol (CBD), highlighting its growing popularity and therapeutic potential following media coverage by Dr. Sanjay Gupta. The article features insights from industry figures Patrick O'Malley of Good Life Colorado and Dr. Noel Palmer of Mary's Medicinals regarding CBD's expanding market beyond medical marijuana demographics.PR NewswireMary's Medicinals Products Now Available to Illinois Medical Cannabis Patients Through a Unique Partnership with GTIMM Technology Holdings, parent company of Mary's Medicinals, has partnered with Green Thumb Industries (GTI) to produce and distribute Mary's Medicinals transdermal cannabis products to medical cannabis patients in Illinois. The partnership gives Illinois patients access to Mary's product line including patches, transdermal gels, and topical compounds known for their dosing accuracy and delivery mechanisms. Mary's Medicinals, which was first to market with THCa and CBN products, currently operates in seven states and plans to expand into additional markets later this year.